Primary Objectives:~To determine the effectiveness of prospective, intensive lymphedema screening in the postoperative setting using a perometer for reducing the cumulative incidence of grade lymphedema among breast cancer patients after ALND compared to routine screening. Secondary Objectives:~To estimate the direct costs associated with the Lymphedema Screening Initiative~To determine the association of the Initiative on patient productivity~To determine patient satisfaction with the Lymphedema Initiative in the context of their cancer care~To determine patient understanding of lymphedema-associated symptoms~To determine patient self-reported compliance with treatments and measures to prevent lymphedema~To determine the incidence of breast cancer-related lymphedema among a cohort of breast cancer patients treated with ALND To analyze clinical and pathological features associated with the development of lymphedema
This research study is to learn about breast cancer patients' opinions about screening for lymphedema (a side effect of breast cancer treatment in which the arm can become heavy, painful, and/or swollen) and their satisfaction with the lymphedema screening program.